How do cancer cells develop resistance to chemotherapy agents?

How do cancer cells develop resistance to chemotherapy agents?

• A. Through lifestyle changes
• B. By increasing drug absorption
• C. Through drug efflux and altered targets
• D. By enhancing nutrient uptake

Answer: (C)

Cancer cells can develop resistance to chemotherapy agents primarily through mechanisms such as drug efflux and altered targets. Drug efflux refers to the ability of cancer cells to actively pump out chemotherapy drugs, decreasing the concentration of the drug inside the cell and thus reducing its effectiveness. This is often facilitated by proteins such as P-glycoprotein, which act as transporters to expel the drugs from the cell. In addition to drug efflux, cancer cells can also alter their drug targets. When the molecular target of a chemotherapy drug undergoes mutations or changes in expression, the drug may no longer fit effectively or engage its target, rendering the treatment less potent or completely ineffective. This dual mechanism of evasion—both by expelling the drugs and altering the targets—leads to a more resilient cancer cell population that can survive even in the presence of treatment. Other options like lifestyle changes, increased drug absorption, and enhanced nutrient uptake do not directly contribute to the core mechanisms by which cancer cells counteract chemotherapy. While lifestyle changes may affect overall health and treatment response, they are not a cellular mechanism for resistance. Increased drug absorption would actually make chemotherapy more effective, not less, and enhanced nutrient uptake does not play a direct role in resistance mechanisms relating

Cancer cells can develop resistance to chemotherapy agents primarily through mechanisms such as drug efflux and altered targets. Drug efflux refers to the ability of cancer cells to actively pump out chemotherapy drugs, decreasing the concentration of the drug inside the cell and thus reducing its effectiveness. This is often facilitated by proteins such as P-glycoprotein, which act as transporters to expel the drugs from the cell.

In addition to drug efflux, cancer cells can also alter their drug targets. When the molecular target of a chemotherapy drug undergoes mutations or changes in expression, the drug may no longer fit effectively or engage its target, rendering the treatment less potent or completely ineffective. This dual mechanism of evasion—both by expelling the drugs and altering the targets—leads to a more resilient cancer cell population that can survive even in the presence of treatment.

Other options like lifestyle changes, increased drug absorption, and enhanced nutrient uptake do not directly contribute to the core mechanisms by which cancer cells counteract chemotherapy. While lifestyle changes may affect overall health and treatment response, they are not a cellular mechanism for resistance. Increased drug absorption would actually make chemotherapy more effective, not less, and enhanced nutrient uptake does not play a direct role in resistance mechanisms relating